Merck Files Second Suit Against Teva Over Singulair
Not content to bring just one suit against Teva Pharmaceuticals USA over a generic version of asthma and allergy medication Singulair, Merck & Co. Inc. let a Barbados-based subsidiary file a...To view the full article, register now.
Already a subscriber? Click here to view full article